Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis

Introduction A major development in solid malignancy treatment is the application of immune checkpoint inhibitors (ICIs), which have produced durable responses and increased survival rates. However, the therapeutic effect of ICIs has great heterogeneity in patients with cancer. We propose a systemat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoguang Yang, Yunming Li, Xuemei Xiang, Wang Guo, Pengfei Zhou
Format: Article
Language:English
Published: BMJ Publishing Group 2022-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/8/e058692.full
Tags: Add Tag
No Tags, Be the first to tag this record!